STOCK TITAN

BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences
Rhea-AI Summary
BD (Becton, Dickinson and Company) announces the next installment of its BD Innovates series focusing on solutions for Peripheral Vascular Disease. The presentation will highlight innovations supporting BD's 2025 Strategy, emphasizing the Peripheral Vascular Disease platform within the BD Peripheral Intervention business unit.
Positive
  • None.
Negative
  • None.

FRANKLIN LAKES, N.J., Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will highlight BD solutions that help clinicians treat Peripheral Vascular Disease — on Monday, February 26, 2024, at 3:00 PM Eastern Time.

The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy, with this installment highlighting the Peripheral Vascular Disease platform within the BD Peripheral Intervention business unit.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and on X (formerly known as Twitter) @BDandCo.

Contacts:




Media:                  

Investors:

Troy Kirkpatrick                

Adam Reiffe

VP, Public Relations        

Sr. Director, Investor Relations

858.617.2361           

201.847.6927      

troy.kirkpatrick@bd.com            

adam.reiffe@bd.com

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-present-next-installment-of-bd-innovates-series-spotlight-on-peripheral-vascular-disease-302059968.html

SOURCE BD (Becton, Dickinson and Company)

BD will present the next installment of its BD Innovates series on Monday, February 26, 2024, at 3:00 PM Eastern Time.

The presentation will highlight BD solutions for treating Peripheral Vascular Disease.

The live webcast of BD's presentation can be accessed from the BD investor relations website at investors.bd.com.

Yes, a replay of the event will be available on the same webpage following its conclusion.
Becton Dickinson & Co.

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Franklin Lakes

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.